
Catherine R. Oliver-garcia
Examiner (ID: 9259, Phone: (571)272-2655 , Office: P/2914 )
| Most Active Art Unit | 2914 |
| Art Unit(s) | 2904, 2900, 2914 |
| Total Applications | 7479 |
| Issued Applications | 7429 |
| Pending Applications | 0 |
| Abandoned Applications | 54 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6260015
[patent_doc_number] => 20020187507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-12
[patent_title] => 'Polynucleotides related to pancreatic disease'
[patent_app_type] => new
[patent_app_number] => 10/165835
[patent_app_country] => US
[patent_app_date] => 2002-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22398
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20020187507.pdf
[firstpage_image] =>[orig_patent_app_number] => 10165835
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/165835 | Polynucleotides related to pancreatic disease | Jun 5, 2002 | Abandoned |
Array
(
[id] => 6791922
[patent_doc_number] => 20030087266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-08
[patent_title] => 'IGs as modifiers of the p53 pathway and methods of use'
[patent_app_type] => new
[patent_app_number] => 10/161572
[patent_app_country] => US
[patent_app_date] => 2002-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16595
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20030087266.pdf
[firstpage_image] =>[orig_patent_app_number] => 10161572
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/161572 | IGs as modifiers of the p53 pathway and methods of use | Jun 2, 2002 | Abandoned |
Array
(
[id] => 6692569
[patent_doc_number] => 20030040001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-27
[patent_title] => 'LETM1: modulators of cellular proliferation'
[patent_app_type] => new
[patent_app_number] => 10/160663
[patent_app_country] => US
[patent_app_date] => 2002-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 14555
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20030040001.pdf
[firstpage_image] =>[orig_patent_app_number] => 10160663
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/160663 | LETM1: modulators of cellular proliferation | May 30, 2002 | Issued |
Array
(
[id] => 1073885
[patent_doc_number] => 06838550
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-01-04
[patent_title] => 'Suppressors of death domains'
[patent_app_type] => utility
[patent_app_number] => 10/161346
[patent_app_country] => US
[patent_app_date] => 2002-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3995
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/838/06838550.pdf
[firstpage_image] =>[orig_patent_app_number] => 10161346
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/161346 | Suppressors of death domains | May 29, 2002 | Issued |
Array
(
[id] => 556656
[patent_doc_number] => 07160993
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-01-09
[patent_title] => 'Nucleic acids encoding PRO4400 polypeptides'
[patent_app_type] => utility
[patent_app_number] => 10/152375
[patent_app_country] => US
[patent_app_date] => 2002-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 550
[patent_figures_cnt] => 550
[patent_no_of_words] => 58852
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/160/07160993.pdf
[firstpage_image] =>[orig_patent_app_number] => 10152375
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/152375 | Nucleic acids encoding PRO4400 polypeptides | May 20, 2002 | Issued |
Array
(
[id] => 1080223
[patent_doc_number] => 06835381
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-12-28
[patent_title] => 'Methods for modulating angiogenesis by using the anti-angiogenic angiotensin-7 and polynucleotides encoding therefor'
[patent_app_type] => B1
[patent_app_number] => 10/018386
[patent_app_country] => US
[patent_app_date] => 2002-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 26308
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/835/06835381.pdf
[firstpage_image] =>[orig_patent_app_number] => 10018386
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/018386 | Methods for modulating angiogenesis by using the anti-angiogenic angiotensin-7 and polynucleotides encoding therefor | May 16, 2002 | Issued |
| 10/129848 | Depletion of cellular coenzyme-a levels as a means to selectively kill cancer cells | May 9, 2002 | Abandoned |
Array
(
[id] => 6829779
[patent_doc_number] => 20030180837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-25
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/063510
[patent_app_country] => US
[patent_app_date] => 2002-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 169
[patent_figures_cnt] => 169
[patent_no_of_words] => 45528
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20030180837.pdf
[firstpage_image] =>[orig_patent_app_number] => 10063510
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/063510 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Apr 30, 2002 | Issued |
Array
(
[id] => 122083
[patent_doc_number] => 07704496
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-27
[patent_title] => 'Antibodies against PRO1341 polypeptide'
[patent_app_type] => utility
[patent_app_number] => 10/128692
[patent_app_country] => US
[patent_app_date] => 2002-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 550
[patent_figures_cnt] => 550
[patent_no_of_words] => 58833
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/704/07704496.pdf
[firstpage_image] =>[orig_patent_app_number] => 10128692
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/128692 | Antibodies against PRO1341 polypeptide | Apr 22, 2002 | Issued |
Array
(
[id] => 556020
[patent_doc_number] => 07157248
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-01-02
[patent_title] => 'CDNA encoding the human α2 δ4 calcium channel subunit'
[patent_app_type] => utility
[patent_app_number] => 10/119624
[patent_app_country] => US
[patent_app_date] => 2002-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 25086
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/157/07157248.pdf
[firstpage_image] =>[orig_patent_app_number] => 10119624
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/119624 | CDNA encoding the human α2 δ4 calcium channel subunit | Apr 9, 2002 | Issued |
Array
(
[id] => 982047
[patent_doc_number] => 06926890
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-08-09
[patent_title] => 'Non-invasive approach for assessing tumors in living animals'
[patent_app_type] => utility
[patent_app_number] => 10/114030
[patent_app_country] => US
[patent_app_date] => 2002-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 6584
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/926/06926890.pdf
[firstpage_image] =>[orig_patent_app_number] => 10114030
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/114030 | Non-invasive approach for assessing tumors in living animals | Apr 2, 2002 | Issued |
| 10/019348 | Prostate-specific polynucleotides, polypeptides and their methods of use | Apr 1, 2002 | Abandoned |
Array
(
[id] => 6797460
[patent_doc_number] => 20030176334
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'Methods and compositions useful for inhibition of angiogenesis'
[patent_app_type] => new
[patent_app_number] => 10/115223
[patent_app_country] => US
[patent_app_date] => 2002-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 46
[patent_no_of_words] => 40382
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20030176334.pdf
[firstpage_image] =>[orig_patent_app_number] => 10115223
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/115223 | Methods and compositions useful for inhibition of angiogenesis | Apr 1, 2002 | Abandoned |
Array
(
[id] => 6527394
[patent_doc_number] => 20020192729
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-19
[patent_title] => 'Apo-2LI and Apo-3 polypeptides'
[patent_app_type] => new
[patent_app_number] => 10/112793
[patent_app_country] => US
[patent_app_date] => 2002-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 24174
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20020192729.pdf
[firstpage_image] =>[orig_patent_app_number] => 10112793
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/112793 | Apo-2LI and Apo-3 polypeptides | Mar 27, 2002 | Abandoned |
Array
(
[id] => 6710497
[patent_doc_number] => 20030170246
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'Lipophilin complexes for use in cancer diagnosis and therapy'
[patent_app_type] => new
[patent_app_number] => 10/096319
[patent_app_country] => US
[patent_app_date] => 2002-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 26565
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20030170246.pdf
[firstpage_image] =>[orig_patent_app_number] => 10096319
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/096319 | Lipophilin complexes for use in cancer diagnosis and therapy | Mar 11, 2002 | Abandoned |
Array
(
[id] => 6778570
[patent_doc_number] => 20030049651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-13
[patent_title] => 'Tumor associated proteins'
[patent_app_type] => new
[patent_app_number] => 10/092012
[patent_app_country] => US
[patent_app_date] => 2002-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 17324
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20030049651.pdf
[firstpage_image] =>[orig_patent_app_number] => 10092012
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/092012 | Tumor associated proteins | Mar 4, 2002 | Abandoned |
Array
(
[id] => 6306076
[patent_doc_number] => 20020094542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-18
[patent_title] => 'Drugs and methods for treating cancer'
[patent_app_type] => new
[patent_app_number] => 10/087252
[patent_app_country] => US
[patent_app_date] => 2002-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18587
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20020094542.pdf
[firstpage_image] =>[orig_patent_app_number] => 10087252
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/087252 | Drugs and methods for treating cancer | Feb 28, 2002 | Abandoned |
Array
(
[id] => 6156643
[patent_doc_number] => 20020146389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-10
[patent_title] => 'DNA19355 polypeptide, a tumor necrosis factor homolog'
[patent_app_type] => new
[patent_app_number] => 10/080455
[patent_app_country] => US
[patent_app_date] => 2002-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 20064
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20020146389.pdf
[firstpage_image] =>[orig_patent_app_number] => 10080455
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/080455 | DNA19355 polypeptide, a tumor necrosis factor homolog | Feb 21, 2002 | Abandoned |
Array
(
[id] => 1101382
[patent_doc_number] => 06815166
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-11-09
[patent_title] => 'HIN-1, a tumor suppressor gene'
[patent_app_type] => B2
[patent_app_number] => 10/081817
[patent_app_country] => US
[patent_app_date] => 2002-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 54
[patent_no_of_words] => 19368
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/815/06815166.pdf
[firstpage_image] =>[orig_patent_app_number] => 10081817
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/081817 | HIN-1, a tumor suppressor gene | Feb 21, 2002 | Issued |
Array
(
[id] => 6274742
[patent_doc_number] => 20020106376
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-08
[patent_title] => 'Therapeutic or prophylactic composition of fibronectin-binding protein 1 (SFBI) as adjuvant'
[patent_app_type] => new
[patent_app_number] => 10/059670
[patent_app_country] => US
[patent_app_date] => 2002-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6210
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20020106376.pdf
[firstpage_image] =>[orig_patent_app_number] => 10059670
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/059670 | Therapeutic or prophylactic composition of fibronectin-binding protein 1 (SFBI) as adjuvant | Jan 29, 2002 | Abandoned |